Intensity of antianginal therapy in patients referred for coronary angiography: A comparison of fee-for-service and health maintenance organization therapeutic strategies
Ba. Samuels et al., Intensity of antianginal therapy in patients referred for coronary angiography: A comparison of fee-for-service and health maintenance organization therapeutic strategies, CLIN CARD, 23(3), 2000, pp. 165-170
Background: No formal criteria have been developed to guide medical therapy
for angina prior to revascularization, and no comparisons have been made b
etween health maintenance organization (HMO) and fee-for-service (FFS) hosp
itals with respect to angina treatment.
Hypothesis: Using a literature-based measure of medical intensity, we teste
d the hypothesis that there is no difference in anginal medical therapeutic
intensity between HMO and FFS systems.
Methods: For each,antianginal drug, we developed a model from which an inte
nsity score between 0 and 100 could be calculated. Average and maximal dail
y doses of drug were fit to a sigmoid curve such that they represented scor
es of 50 and 99 respectively. Overall intensity scores were obtained by wei
ghted and unweighted averaging of three scores from nitrates, calcium-chann
el blockers, and beta blockers. This model was applied to 199 patients unde
rgoing angiography at an FFS and an HMO hospital.
Results: HMO patients wen taking more classes of antianginal drug (1.9 vs.
1.0, p < 0.001). Overall unweighted (17.7 vs. 11.7, p = 0.02) and weighted
(27.3 vs. 16.9, p = 0.003) intensity scores for both HMO and FFS patients w
ere low. HMO intensity scores for the use of beta blockers were greater tha
n FFS scores (19.2 vs. 9.6, p = 0.002). The intensity scores for the use of
nitrates and calcium blockers were similar.
Conclusions: Models for the measurement of anginal medical therapy intensit
y can provide important information regarding medical therapy prior to reva
scularization. The overall intensity of medical therapy was low in both hea
lth care systems. These findings have important implications for patient ma
nagement, guideline development, and national healthcare policy.